Detalhe da pesquisa
1.
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.
Hepatology
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607809
2.
Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
Dig Dis Sci
; 68(8): 3442-3450, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37213003
3.
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
J Hepatol
; 75(5): 1026-1033, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166722
4.
Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
Dig Dis Sci
; 66(9): 3199-3208, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33033975
5.
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.
JHEP Rep
; 5(8): 100727, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37456675
6.
Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.
World J Gastroenterol
; 27(28): 4639-4652, 2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34366626
7.
Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes.
Eur J Gastroenterol Hepatol
; 31(9): 1157-1164, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385871